This site requires javascript. Please turn that on in your browser\'s preferences. How?

Axis Neuromonitoring Axis Neuromonitoring

Johnson & Johnson to split into 2 companies

By Admin | November 10, 2021

Johnson & Johnson is dividing into two separate companies; one will focus on its medical devices and drugs, and the other will focus on consumer health products.

Completion of the separation is expected in 18 to 24 months, according to a Nov. 12 news release. On Jan. 3, Joaquin Duato will take over as CEO of Johnson & Johnson.

Johnson & Johnson will continue focusing on pharmaceuticals and medical devices, including orthopedics. The new consumer health company will focus on consumer products, including bandages, lotions and Tylenol.

The planned separation of consumer health is expected to accelerate the company's efforts to serve patients, CEO Alex Gorsky said...(More)

For more info please read, Johnson & Johnson to split into 2 companies, by Becker's SpineRevew

« Return to ALL NEWS